Skip to main content

Van Plew Daniel P's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 25, 2023

Accession no.
0001968202-23-000028
Filed
Aug 25, 2023
Trade date
Aug 23-24, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 12 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.22M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Van Plew Daniel PCIK 0001411984Officer (EVP & General Mgr, Industrial)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 23, 2023Common StockMOption exerciseAcquired+23,125$381.40+$8,819,87544,633Direct
Aug 23, 2023Common StockFTax withholdingDisposed−16,928$842.66−$14,264,548.4827,705Direct
Aug 24, 2023Common StockSSaleDisposed−138$835.67F1−$115,322.4627,567Direct
Aug 24, 2023Common StockSSaleDisposed−625$836.32F2−$522,70026,942Direct
Aug 24, 2023Common StockSSaleDisposed−300$837.53−$251,25926,642Direct
Aug 24, 2023Common StockSSaleDisposed−667$838.37F3−$559,192.7925,975Direct
Aug 24, 2023Common StockSSaleDisposed−148$839.28F4−$124,213.4425,827Direct
Aug 24, 2023Common StockSSaleDisposed−46$840.74−$38,674.0425,781Direct
Aug 24, 2023Common StockSSaleDisposed−363$841.15F5−$305,337.4525,418Direct
Aug 24, 2023Common StockSSaleDisposed−617$842.66F6−$519,921.2224,801Direct
Aug 24, 2023Common StockSSaleDisposed−759$843.31F7−$640,072.2924,042Direct
Aug 24, 2023Common StockSSaleDisposed−2,534$844.27F8−$2,139,380.1821,508Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 23, 2023Common StockMOption exerciseDisposed−23,125$0.00$023,125Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents volume-weighted average price of sales of 138 shares of Company stock on August 24, 2023 at prices ranging from $835.58 to $835.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

Represents volume-weighted average price of sales of 625 shares of Company stock on August 24, 2023 at prices ranging from $836.10 to $836.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 667 shares of Company stock on August 24, 2023 at prices ranging from $838.06 to $838.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 148 shares of Company stock on August 24, 2023 at prices ranging from $839.08 to $839.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 363 shares of Company stock on August 24, 2023 at prices ranging from $841.03 to $841.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 617 shares of Company stock on August 24, 2023 at prices ranging from $842.28 to $842.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 759 shares of Company stock on August 24, 2023 at prices ranging from $843.04 to $843.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 2,534 shares of Company stock on August 24, 2023 at prices ranging from $844.02 to $844.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)